Expression of tissue inhibitor of matrix metalloproteinases 1 by use of anadenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury

Citation
Cm. Dollery et al., Expression of tissue inhibitor of matrix metalloproteinases 1 by use of anadenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury, CIRCULATION, 99(24), 1999, pp. 3199-3205
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
99
Issue
24
Year of publication
1999
Pages
3199 - 3205
Database
ISI
SICI code
0009-7322(19990622)99:24<3199:EOTIOM>2.0.ZU;2-3
Abstract
Background-Cell migration is a major contributor to injury-induced neointim al hyperplasia and depends on alteration of the proteolytic balance within the arterial wall toward matrix breakdown. This is partly mediated by the m atrix metalloproteinases (MMPs) and their natural inhibitors, the tissue in hibitors of metalloproteinases (TIMPs). Methods and Results-An increase in expression of biologically active and im munoreactive TIMP-1 was seen in vitro after infection of rat smooth muscle cells (SMCs) with Av1.TIMP1 (an adenoviral vector containing the human TLMP 1 cDNA), Infection of rat SMCs with Av1.TIMP1 reduced migration in vitro by 27% compared with control virus-infected cells (37.6 +/- 4.34 versus 51 +/ - 5.01 cells per high-power field, P < 0.05), The adenoviral vector was del ivered to the injured rat carotid artery, and 4 days later, immunoreactive protein was identified and migration of SMCs reduced by 60% (5.2 +/- 0.5 ve rsus 12.8 +/- 1.5 cells per section, P < 0.05, n = 5), Neointimal area 14 d ays after injury showed a 30% reduction in the animals receiving the Av1.TI MP1 virus compared with controls (0.09 +/- 0.01 versus 0.14 +/- 0.01 mm(2), P = 0.02, n = 14), Conclusions-The response to arterial balloon injury involves MMP-dependent SMC migration and can be attenuated in vivo by the transmural expression of TIMP-1 by adenoviral gene transfer.